Four pillars. One senior, founder-led practice.

Every engagement is delivered end-to-end by a GPhC-registered pharmacist and Final Medical Signatory — no hand-offs to juniors. Running through all four pillars is a single thread: pharmaceutical strategy & portfolio advisory, turning complex options into one clear, compliant, commercially viable plan.

1

Regulatory Affairs & Product Lifecycle

Submissions, variations and licence maintenance — with deep post-Brexit UK expertise.

End-to-end regulatory strategy and lifecycle management across UK, EU, Gulf and international pathways — new applications, variations, renewals, SmPC/PIL and product information — supported by CMC and technical dossier expertise from formulation through to Module 3 filing. We keep your portfolio compliant, current and commercially relevant.

Services under this pillar

2

Medical Information, Final Signatory & Compliance

ABPI/PMCPA certification and an inspection-ready medical information service.

Led by a nominated Final Medical Signatory under the ABPI Code — MLR review, certification and examination of promotional and non-promotional materials — alongside senior medical affairs, scientific advisory, medical writing, and a compliant medical information service handling HCP, patient and carer enquiries to inspection-ready standard. This pillar protects both your brand and your patients.

Services under this pillar

3

Pharmacovigilance & Safety Governance

PSMF, RMPs and ICSR pathways built to GVP and MHRA inspection standard.

Pharmacovigilance systems built and maintained to inspection-ready standard — PSMF, risk management plans, ICSR and safety-escalation pathways, SOPs, training, CAPA and audit readiness — aligned to GVP and MHRA expectations. Informed by experience as UK National Contact Person and co-development of an affiliate pharmacovigilance framework with the UK QPPV.

Services under this pillar

4

Market Access & Cross-Border Expansion

NHS listing, Drug Tariff, category switch and bi-directional UK ↔ Gulf reach.

UK market access and commercial strategy — pricing and reimbursement, NHS listing, dm+d visibility, Drug Tariff, formulary access and category switch — engineered for launch success and sustainable uptake. Extended by a proven bi-directional UK ↔ Gulf track record spanning product registration, local-partner ventures and investor-facing support.

Services under this pillar

CAPABILITY OVERVIEW

Want the full picture in one document?

The pillar flyers above profile the founder's expertise in each area. For the complete practice — all four pillars and nine specialist services — download the full Saviours Pharma capability overview.

Download master flyer